| Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients R Colodner, W Rock, B Chazan, N Keller, N Guy, W Sakran, R Raz European journal of clinical microbiology and infectious diseases 23, 163-167, 2004 | 596 | 2004 |
| Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections D Ben-David, R Kordevani, N Keller, I Tal, A Marzel, O Gal-Mor, Y Maor, ... Clinical Microbiology and Infection 18 (1), 54-60, 2012 | 448 | 2012 |
| Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome M Blank, I Krause, M Fridkin, N Keller, J Kopolovic, I Goldberg, A Tobar, ... The Journal of clinical investigation 109 (6), 797-804, 2002 | 439 | 2002 |
| Nasopharyngeal Carriage of Streptococcus pneumoniae by Adults and Children in Community and Family Settings G Regev-Yochay, M Raz, R Dagan, N Porat, B Shainberg, E Pinco, ... Clinical Infectious Diseases 38 (5), 632-639, 2004 | 410 | 2004 |
| An Outbreak of Phialemonium Infective Endocarditis Linked to Intracavernous Penile Injections for the Treatment of Impotence J Strahilevitz, G Rahav, HJ Schroers, RC Summerbell, Z Amitai, ... Clinical infectious diseases 40 (6), 781-786, 2005 | 402 | 2005 |
| Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997–1999 DE Low, N Keller, A Barth, RN Jones Clinical Infectious Diseases 32 (Supplement_2), S133-S145, 2001 | 386 | 2001 |
| Listeria monocytogenes infection in Israel and review of cases worldwide Y Siegman-Igra, R Levin, M Weinberger, Y Golan, D Schwartz, Z Samra, ... Emerging infectious diseases 8 (3), 305, 2002 | 297 | 2002 |
| Rhino-orbital and rhino-orbito-cerebral mucormycosis YP Talmi, A Goldschmied-Reouven, M Bakon, I Barshack, M Wolf, ... Otolaryngology—Head and Neck Surgery 127 (1), 22-31, 2002 | 290 | 2002 |
| Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection D Ben-David, Y Maor, N Keller, G Regev-Yochay, I Tal, D Shachar, ... Infection Control & Hospital Epidemiology 31 (6), 620-626, 2010 | 226 | 2010 |
| Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection R Ben-Ami, K Olshtain-Pops, M Krieger, I Oren, J Bishara, M Dan, ... Antimicrobial agents and chemotherapy 56 (5), 2518-2523, 2012 | 214 | 2012 |
| Clinical Features of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia versus Those of Methicillin-Resistant S. aureus Bacteremia Y Maor, M Hagin, N Belausov, N Keller, D Ben-David, G Rahav The Journal of infectious diseases 199 (5), 619-624, 2009 | 204 | 2009 |
| Rapid Detection of blaKPC Carbapenemase Genes by Real-Time PCR M Hindiyeh, G Smollen, Z Grossman, D Ram, Y Davidson, F Mileguir, ... Journal of clinical microbiology 46 (9), 2879-2883, 2008 | 204 | 2008 |
| Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers R Neeman, N Keller, A Barzilai, Z Korenman, S Sela The Lancet 352 (9145), 1974-1977, 1998 | 186 | 1998 |
| Feasibility of using recombinant factor VIIa in continuous infusion S Schulman, MB Jensen, D Varon, N Keller, N Gitel, H Horoszowski, ... Thrombosis and haemostasis 75 (03), 432-436, 1996 | 154 | 1996 |
| Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit G Regev-Yochay, E Rubinstein, A Barzilai, Y Carmeli, J Kuint, J Etienne, ... Emerging infectious diseases 11 (3), 453, 2005 | 150 | 2005 |
| The use of porphyrins for eradication of Staphylococcus aureus in burn wound infections A Orenstein, D Klein, J Kopolovic, E Winkler, Z Malik, N Keller, Y Nitzan FEMS Immunology & Medical Microbiology 19 (4), 307-314, 1997 | 149 | 1997 |
| Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality M Weinberger, L Leibovici, S Perez, Z Samra, I Ostfeld, I Levi, E Bash, ... Journal of Hospital Infection 61 (2), 146-154, 2005 | 127 | 2005 |
| Prevalence and Characteristics of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia in a Tertiary Care Center Y Maor, G Rahav, N Belausov, D Ben-David, G Smollan, N Keller Journal of clinical microbiology 45 (5), 1511-1514, 2007 | 118 | 2007 |
| Nosocomial bloodstream infections in a pediatric intensive care unit: 3-year survey G Grisaru-Soen, Y Sweed, L Lerner-Geva, G Hirsh-Yechezkel, V Boyko, ... Medical science monitor 13 (6), CR251-CR257, 2007 | 112 | 2007 |
| Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa U Hedner Thrombosis and haemostasis 82 (08), 531-539, 1999 | 110 | 1999 |